Artha Sootra - Company Dashboard

Governance Classic Home

Morepen Laboratories LtdPharmaceuticalsINE083A01026Consolidated₹101.33-0.98 (-0.96%)

Valuation

Market Cap₹5.55K Cr

TTM PE29.54x

Forward PE25.94x

PEG0.87

Book Value₹25.21

P/B4.02x

TTM EPS₹3.43

Fwd EPS₹3.91

TTM Revenue₹2.29K Cr

TTM PAT₹188.54 Cr

TTM EBITDA₹276.42 Cr

TTM EBIT₹241.87 Cr

Last Qtr PAT₹88.89 Cr

Last Qtr EBITDA₹123.11 Cr

Last Qtr EBIT₹113.04 Cr

Profitability

ROE13.65%

ROCE15.73%

TTM NPM8.25%

TTM EBITDA %12.09%

Curr OPM11.77%

Last OPM9.80%

Curr NPM—

Last NPM—

Curr EPS₹1.62

Last EPS₹1.03

Balance sheet

Equity₹109.58 Cr

Reserve₹1.27K Cr

Total Debt₹322.96 Cr

D/E0.23x

Interest %5.84%

Curr Interest₹5.19 Cr

Price / range

Close₹101.33

vs 52W High—

vs 52W Low—

MA50—

MA200—

Returns

1D-0.96%

1W-19.31%

1M-24.22%

3M+46.47%

6M+141.26%

1Y+110.18%

2Y+25.97%

3Y+180.07%

5Y+98.10%

Diwali+146.67%

Sector peers — Pharmaceuticals

Company	Close	Mkt Cap	TTM P/E	ROE
SUNPHARMA	1773.40	₹4.25L Cr	38.81	12.31%
DIVISLAB	10037.50	₹2.66L Cr	91.08	17.45%
TORNTPHARM	4738.50	₹1.60L Cr	77.77	11.42%
LAURUSLABS	2323.80	₹1.25L Cr	93.63	21.98%
ZYDUSLIFE	1188.10	₹1.20L Cr	28.53	15.79%
DRREDDY	1374.00	₹1.15L Cr	40.89	7.11%
CIPLA	1402.00	₹1.13L Cr	39.09	8.06%
MANKIND	2537.90	₹1.05L Cr	46.71	12.87%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Metric	Sep-26	Jun-26	Mar-26	Dec-25	Sep-25	FY25-26
Revenue	678+83.5%	541.04	462.81	457.57	369.53	1,681.20
Other Income	8.43	5.31	8.82	3.93	4.65	21.50
Total Income	686.43+83.4%	546.35	471.63	461.50	374.18	1,702.69
Interest	5.10	4.78	3.87	4.31	4.11	16.10
Expenditure	-582.78-63.5%	-474.20	-444	-430.08	-356.41	-1,614.52
PBDT	0	0	0	0	0	0
EBITDA	110.02+293.9%	79.60	23.31	41.89	27.93	112.09
Depreciation	-9.70	-7.98	-0.63	-10.09	-10.70	-29.31
EBIT	100.32+482.2%	71.62	22.68	31.80	17.23	82.78
PBT	103.65+449.6%	72.15	27.63	31.42	18.86	89.26
Tax	-25.78	-18.15	-7.50	-7.93	-4.49	-23.21
Equity	109.58	109.58	109.58	0	0	109.58
OPM	15.10	13.21	5.86	6.87	5.10	5.24
Net Profit	77.87+441.5%	54	20.12	23.50	14.38	66.06
NPM	11.34	9.88	4.27	5.13	3.89	3.88
EPS	1.42+446.2%	0.99	0.37	0.43	0.26	1.21

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23	FY 21-22	FY 20-21
Revenue	1,681.20+8.1%	1,554.54+1.1%	1,537.59+14.8%	1,338.88-7.6%	1,449.27+30.3%	1,112.42
Other Income	21.50	15.72	12.57	5.76	10.24	11.77
Total Income	1,702.69+8.4%	1,570.25+1.3%	1,550.16+15.3%	1,344.64-7.9%	1,459.50+29.8%	1,124.20
Expenditure	-1,614.52-12.7%	-1,432.67-2.2%	-1,401.18-9.3%	-1,281.60+3.9%	-1,333.96-29.5%	-1,029.95
Interest	-16.10	-7.10	-3.51	-1.98	7.37	-1.79
PBDT	0	0	0	0	0	0
EBITDA	112.09-26.9%	153.41-5.2%	161.82+109.4%	77.27-46.3%	143.88+28.0%	112.37
Depreciation	-29.31	-24.44	-21.90	-18.01	-21.20	-28.11
EBIT	82.78-35.8%	128.97-7.8%	139.92+136.1%	59.26-51.7%	122.68+45.6%	84.26
PBT	89.26-35.1%	137.59-7.6%	148.98+136.3%	63.04-49.8%	125.54+33.2%	94.25
Tax	-23.21	-36.01	-38.04	-16.80	-24.48	0
Equity	109.58	109.58	0	0	0	0
OPM (%)	5.24	8.76	10.00	5.00	9.00	8.00
Net Profit	66.06-35.0%	101.58-8.4%	110.94+139.9%	46.24-54.2%	101.06+7.2%	94.25
NPM (%)	3.88	6.47	7.00	3.00	7.00	8.00
EPS (Rs)	1.21-36.3%	1.90-12.4%	2.17+135.9%	0.92-59.1%	2.25+7.1%	2.10
CEPS	1.21	1.90	2.17	0.92	1.94	2.09

Metric	Sep-26	Jun-26	Mar-26	Dec-25	Sep-25	FY25-26
Revenue	746.50+81.4%	570.13	484.72	484.16	411.58	1,805.69
Other Income	8.69	5.18	8.46	3.81	4.64	21.31
Total Income	755.19+81.4%	575.31	493.18	487.97	416.21	1,827.01
Interest	5.19	4.84	3.88	4.32	4.18	16.41
Expenditure	-638.65-61.1%	-500.78	-469.89	-452.55	-396.34	-1,732.91
PBDT	0	0	0	0	0	0
EBITDA	123.11+301.0%	82.54	24.46	46.31	30.70	125.62
Depreciation	-10.07	-8.35	-5.75	-10.38	-11.28	-36.43
EBIT	113.04+482.1%	74.19	18.71	35.93	19.42	89.19
PBT	116.54+155.0%	74.53	23.29	35.42	45.70	119.92
Tax	-27.65	-18.18	-7.59	-7.93	-4.65	-24.27
Equity	109.58	109.58	109.58	0	0	109.58
OPM	15.43	12.95	4.72	7.26	10.98	6.56
Net Profit	88.89+117.4%	56.40	15.74	27.51	40.88	94.88
NPM	11.77	9.80	3.19	5.64	9.82	5.19
EPS	1.62+116.0%	1.03	0.28	0.50	0.75	1.73

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23	FY 21-22	FY 20-21
Revenue	1,805.69-0.3%	1,811.58+7.2%	1,690.43+19.3%	1,417.53-8.4%	1,546.83+30.2%	1,188.06
Other Income	21.31	18.36	13.97	6.13	10.31	12.07
Total Income	1,827.01-0.2%	1,829.94+7.4%	1,704.40+19.7%	1,423.66-8.6%	1,557.13+29.7%	1,200.13
Expenditure	-1,732.91-3.5%	-1,674.83-6.7%	-1,568.99-14.7%	-1,367.91+4.4%	-1,430.43-29.8%	-1,101.61
Interest	-16.41	-8.34	-3.71	-1.98	7.37	-1.79
PBDT	0	0	0	0	0	0
EBITDA	125.62-27.8%	174.07+9.7%	158.62+99.4%	79.53-47.5%	151.41+27.8%	118.52
Depreciation	-36.43	-28.98	-33.47	-27.93	-27.64	-30.28
EBIT	89.19-38.5%	145.09+15.9%	125.15+142.5%	51.60-58.3%	123.77+40.3%	88.24
PBT	119.92-22.7%	155.11+14.5%	135.42+142.9%	55.76-56.0%	126.70+28.6%	98.51
Tax	-24.27	-37.09	-38.80	-17.08	-25.02	-1.42
Equity	109.58	109.58	0	0	0	0
OPM (%)	6.56	8.48	7.95	3.92	8.14	8.21
Net Profit	94.88-19.6%	118.02+22.7%	96.16+148.6%	38.68-62.0%	101.68+4.7%	97.09
NPM (%)	5.19	6.45	5.64	2.72	6.53	8.09
EPS (Rs)	1.73-21.4%	2.20+17.0%	1.88+144.2%	0.77-65.9%	2.26+4.6%	2.16
CEPS	1.73	2.20	1.88	0.77	1.96	2.15

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

Year	Type	Amount	Ex-Date
2026	Final Dividend	0.2	18 Sep 2026
2025	Final Dividend	0.2	29 Aug 2025

Bonus

No bonus history.

Split

No split history.

Financial Results

Standalone

Yearly results

Yearly

Consolidated

Yearly results

Yearly

Corporate Actions

Dividend

Bonus

Split